Can Cancer Be Diagnosed with a PET Scan? Understanding its Role

Positron Emission Tomography (PET) scans are powerful imaging tools that play a significant role in modern medicine, especially in oncology. But Can Cancer Be Diagnosed With A Pet Scan? The answer is nuanced. While a PET scan is not solely a diagnostic tool in itself, it provides critical information that aids in the detection, staging, and management of cancer. This article will explore how PET scans work, their effectiveness in cancer diagnosis, and what to expect during the procedure.

What is a PET Scan and How Does it Work?

A PET scan, or Positron Emission Tomography scan, is an advanced imaging technique that reveals how your tissues and organs are functioning at a metabolic level. Unlike other imaging tests like X-rays, CT scans, or MRIs that primarily show the structure of the body, a PET scan highlights biological activity.

This is achieved through the use of a radioactive tracer, a special drug that emits positrons. This tracer is typically injected into a vein and travels through your body. Cells that are more metabolically active, such as cancer cells, absorb more of the tracer. The PET scanner detects the positrons emitted by the tracer and creates detailed 3D images showing areas of high and low metabolic activity. Areas with a high concentration of the tracer appear as “bright spots” on the PET scan images.

Often, PET scans are combined with CT (Computed Tomography) or MRI (Magnetic Resonance Imaging) scans. These combined scans, known as PET-CT or PET-MRI, provide both functional (from PET) and anatomical (from CT/MRI) information in a single image set. This fusion allows doctors to pinpoint the location of abnormal metabolic activity with greater precision, leading to more accurate diagnoses and treatment plans.

PET Scans in Cancer Diagnosis and Management

Cancer cells are characterized by their rapid and uncontrolled growth, which results in a higher metabolic rate compared to normal cells. This increased metabolic activity makes cancer cells readily visible on PET scans. Therefore, PET scans are highly valuable in various aspects of cancer management:

Detecting Cancer: PET scans can detect cancers throughout the body by identifying areas of increased metabolic activity that may indicate cancerous growth. Because PET scans can often detect metabolic changes before structural changes are visible on CT or MRI, they can sometimes identify cancer in its earlier stages.
Staging Cancer: Once cancer is diagnosed, it’s crucial to determine if and how far it has spread – a process called staging. PET scans are effective in identifying if cancer has metastasized, or spread, to other parts of the body, such as lymph nodes or distant organs. This is critical for determining the appropriate treatment strategy and predicting prognosis.
Monitoring Treatment Effectiveness: PET scans can be used to assess how well cancer treatment, such as chemotherapy or radiation therapy, is working. By comparing PET scans taken before, during, and after treatment, doctors can determine if the metabolic activity of the tumor is decreasing, indicating a positive response to treatment.
Detecting Cancer Recurrence: After cancer treatment, PET scans can help monitor for cancer recurrence. If cancer returns, it often exhibits increased metabolic activity, which can be detected by a PET scan, sometimes even before symptoms reappear or other imaging tests show abnormalities.

Many types of solid tumors can be effectively evaluated with PET-CT and PET-MRI scans. These include cancers of the:

Brain
Breast
Cervix
Colon and Rectum
Esophagus
Head and Neck
Lung
Lymph Nodes (Lymphoma)
Pancreas
Prostate
Skin (Melanoma)
Thyroid

Benefits of PET Scans for Cancer Diagnosis

The use of PET scans in cancer diagnosis offers several key advantages:

Early Detection Potential: PET scans can detect metabolic changes associated with cancer at an earlier stage than some other imaging techniques, potentially leading to earlier diagnosis and treatment.
Improved Accuracy in Staging: PET scans can provide a more accurate assessment of cancer stage by identifying distant metastases that might be missed by other methods. This is crucial for appropriate treatment planning.
Personalized Treatment Monitoring: PET scans allow doctors to monitor a patient’s response to cancer therapy in real-time, enabling adjustments to treatment plans if necessary. This personalized approach can improve treatment outcomes.

Limitations of PET Scans in Cancer Diagnosis

Despite their advantages, PET scans are not without limitations in cancer diagnosis:

False Positives: Non-cancerous conditions, such as infections, inflammation, and benign tumors, can also exhibit increased metabolic activity and appear as “bright spots” on PET scans. This can lead to false-positive results, where a PET scan suggests cancer when it is not actually present. Further investigation and correlation with other clinical findings are crucial to differentiate between cancerous and non-cancerous conditions.
False Negatives: Some cancers, particularly slow-growing or less metabolically active tumors, may not absorb enough of the tracer to be clearly visible on PET scans, resulting in false-negative results. Also, very small tumors may be below the resolution limit of the PET scan.
Not a Standalone Diagnostic Tool: While PET scans provide valuable information, they are typically used in conjunction with other diagnostic tools, such as biopsies, CT scans, MRI scans, and clinical evaluations, to confirm a cancer diagnosis. A PET scan result needs to be interpreted in the context of the patient’s overall clinical picture.

Risks and Preparation for a PET Scan

PET scans are generally safe procedures. The amount of radiation exposure from the tracer is low, and the risk of long-term negative effects is minimal. However, there are a few potential risks:

Radiation Exposure: Although low, there is some radiation exposure associated with the tracer. This is a consideration, especially for pregnant women and children.
Allergic Reaction: Rarely, patients may experience an allergic reaction to the tracer.
Discomfort at Injection Site: There may be mild discomfort or bruising at the injection site.

Preparation for a PET scan typically involves:

Fasting: Patients are usually asked to fast for at least four hours before the scan to ensure accurate results.
Hydration: Drinking plenty of water before and after the scan helps to flush the tracer out of the body.
Informing your doctor: It’s important to inform your doctor about any allergies, medical conditions (especially diabetes), medications, and if you are pregnant or breastfeeding.

What to Expect During a PET Scan

The PET scan procedure is generally straightforward and painless:

Tracer Injection: A radioactive tracer is injected into a vein in your arm or hand.
Waiting Period: You will rest for about 30 to 60 minutes while the tracer distributes throughout your body and is absorbed by the tissues.
Scanning: You will lie on a narrow table that slides into the PET scanner, a large, doughnut-shaped machine. It’s important to remain still during the scan to ensure clear images. The scan itself typically takes about 30 to 45 minutes.
After the Scan: You can usually resume your normal activities after the scan. Drinking plenty of fluids is recommended to help eliminate the tracer from your body.

Conclusion

In conclusion, can cancer be diagnosed with a PET scan? While a PET scan is not a definitive diagnostic test on its own, it is an invaluable tool in the detection, staging, and management of cancer. Its ability to visualize metabolic activity provides unique and critical information that complements other diagnostic methods. If you are concerned about cancer or your doctor has recommended a PET scan, discuss your questions and concerns with your healthcare provider to understand how this technology can contribute to your care.

References:

Positron emission tomography — Computed tomography (PET/CT). Radiological Society of North America. https://www.radiologyinfo.org/en/info.cfm?pg=PET. Accessed April 6, 2021.
What is PET? Society of Nuclear Medicine and Molecular Imaging. https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=5649. Accessed April 6, 2021.
Umterrainer M, et al. Recent advances of PET imaging in clinical radiation oncology. Radiation Oncology. 2020; doi:10.1186/s13014-020-01519-1.
Adam A, et al., eds. Adrenal imaging. In: Grainger and Allison’s Diagnostic Radiology. 7th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed April 6, 2021.
ACR-SPR practice parameters for performing FDG-PET/CT in oncology. American College of Radiology. https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards/Practice-Parameters-by-Modality. Accessed April 6, 2021.
Cervical cancer. Radiological Society of North America. https://www.radiologyinfo.org/en/info.cfm?pg=cervicalcancer. Accessed April 8, 2021.
Morrow ES. Allscripts EPSi. Mayo Clinic. April 6, 2021.
Collins DA (expert opinion). Mayo Clinic. April 24, 2021.